http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16725187

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 90
issn 0270-4137
1097-0045
issueIdentifier 1
pageRange 81-90
publicationName The Prostate
startingPage 81
bibliographicCitation Pinto AC, Moreira JN, Simões S. Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancer. Prostate. 2011 Jan 01;71(1):81–90. doi: 10.1002/pros.21224. PMID: 20607721.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7b282964edd09ab9f052563336e6d15
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b515348da4ad1272b7b5d74b20174dc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_655114566fdfb4184ae22ff8bf1dad4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3449-0522
date 2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20607721
https://doi.org/10.1002/pros.21224
isPartOf https://portal.issn.org/resource/ISSN/0270-4137
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6523
https://portal.issn.org/resource/ISSN/1097-0045
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Liposomal imatinib–mitoxantrone combination: Formulation development and therapeutic evaluation in an animal model of prostate cancer
discusses http://id.nlm.nih.gov/mesh/M0002327
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0016884
http://id.nlm.nih.gov/mesh/M0012600
http://id.nlm.nih.gov/mesh/M0391958
http://id.nlm.nih.gov/mesh/M0013954
http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D010879Q000008
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D011743Q000008
http://id.nlm.nih.gov/mesh/D008942Q000008
http://id.nlm.nih.gov/mesh/D000230Q000188
http://id.nlm.nih.gov/mesh/D011471Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D000068877
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D001549
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008081
http://id.nlm.nih.gov/mesh/D004195
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4212
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a8bd9503aa2b9fdf4fb06029687b8bce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 59.